Skip to main navigation Skip to search Skip to main content

TRx-237-039 LUCIDITY - Randomized, Double-Blind, Placebo-Controlled, Three-Arm, 9-Month, Brain Imaging and Safety and Efficacy Study of Leuco-methylthioninium bis (hydromethanesulfonate) (LMTM) in Subjects with Early Alzheimer's Disease

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date05/28/19 → 05/28/24

Funding

  • Syneos Health LLC: $26,942.42